Interactions of recommended COVID-19 drugs with commonly used psychotropics.
Identifieur interne : 001608 ( Main/Corpus ); précédent : 001607; suivant : 001609Interactions of recommended COVID-19 drugs with commonly used psychotropics.
Auteurs : Seshadri Sekhar Chatterjee ; Barikar C. Malathesh ; Soumitra Das ; Om Prakash SinghSource :
- Asian journal of psychiatry [ 1876-2026 ] ; 2020.
English descriptors
- KwdEn :
- Antiviral Agents (pharmacology), Betacoronavirus (MeSH), COVID-19 (MeSH), Comorbidity (MeSH), Coronavirus Infections (complications), Coronavirus Infections (drug therapy), Coronavirus Infections (epidemiology), Drug Interactions (MeSH), Drug Therapy, Combination (methods), Humans (MeSH), Long QT Syndrome (chemically induced), Long QT Syndrome (prevention & control), Mental Disorders (drug therapy), Mental Disorders (epidemiology), Pandemics (MeSH), Pneumonia, Viral (drug therapy), Pneumonia, Viral (epidemiology), Psychotropic Drugs (pharmacology), Risk Adjustment (methods), SARS-CoV-2 (MeSH).
- MESH :
- chemical , pharmacology : Antiviral Agents, Psychotropic Drugs.
- chemically induced : Long QT Syndrome.
- complications : Coronavirus Infections.
- drug therapy : Coronavirus Infections, Mental Disorders, Pneumonia, Viral.
- epidemiology : Coronavirus Infections, Mental Disorders, Pneumonia, Viral.
- methods : Drug Therapy, Combination, Risk Adjustment.
- prevention & control : Long QT Syndrome.
- Betacoronavirus, COVID-19, Comorbidity, Drug Interactions, Humans, Pandemics, SARS-CoV-2.
DOI: 10.1016/j.ajp.2020.102173
PubMed: 32446195
PubMed Central: PMC7239782
Links to Exploration step
pubmed:32446195Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Interactions of recommended COVID-19 drugs with commonly used psychotropics.</title>
<author><name sortKey="Chatterjee, Seshadri Sekhar" sort="Chatterjee, Seshadri Sekhar" uniqKey="Chatterjee S" first="Seshadri Sekhar" last="Chatterjee">Seshadri Sekhar Chatterjee</name>
<affiliation><nlm:affiliation>Department of Psychiatry, Diamond Harbour Medical College, West Bengal, India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Malathesh, Barikar C" sort="Malathesh, Barikar C" uniqKey="Malathesh B" first="Barikar C" last="Malathesh">Barikar C. Malathesh</name>
<affiliation><nlm:affiliation>Department of Psychiatry, NIMHANS, Bengaluru, India. Electronic address: bc.malathesh@gmail.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Das, Soumitra" sort="Das, Soumitra" uniqKey="Das S" first="Soumitra" last="Das">Soumitra Das</name>
<affiliation><nlm:affiliation>NWMH, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Singh, Om Prakash" sort="Singh, Om Prakash" uniqKey="Singh O" first="Om Prakash" last="Singh">Om Prakash Singh</name>
<affiliation><nlm:affiliation>Department of Psychiatry, West Bengal University of Health Sciences, India.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32446195</idno>
<idno type="pmid">32446195</idno>
<idno type="doi">10.1016/j.ajp.2020.102173</idno>
<idno type="pmc">PMC7239782</idno>
<idno type="wicri:Area/Main/Corpus">001608</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001608</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Interactions of recommended COVID-19 drugs with commonly used psychotropics.</title>
<author><name sortKey="Chatterjee, Seshadri Sekhar" sort="Chatterjee, Seshadri Sekhar" uniqKey="Chatterjee S" first="Seshadri Sekhar" last="Chatterjee">Seshadri Sekhar Chatterjee</name>
<affiliation><nlm:affiliation>Department of Psychiatry, Diamond Harbour Medical College, West Bengal, India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Malathesh, Barikar C" sort="Malathesh, Barikar C" uniqKey="Malathesh B" first="Barikar C" last="Malathesh">Barikar C. Malathesh</name>
<affiliation><nlm:affiliation>Department of Psychiatry, NIMHANS, Bengaluru, India. Electronic address: bc.malathesh@gmail.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Das, Soumitra" sort="Das, Soumitra" uniqKey="Das S" first="Soumitra" last="Das">Soumitra Das</name>
<affiliation><nlm:affiliation>NWMH, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Singh, Om Prakash" sort="Singh, Om Prakash" uniqKey="Singh O" first="Om Prakash" last="Singh">Om Prakash Singh</name>
<affiliation><nlm:affiliation>Department of Psychiatry, West Bengal University of Health Sciences, India.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Asian journal of psychiatry</title>
<idno type="eISSN">1876-2026</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (pharmacology)</term>
<term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Comorbidity (MeSH)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Drug Interactions (MeSH)</term>
<term>Drug Therapy, Combination (methods)</term>
<term>Humans (MeSH)</term>
<term>Long QT Syndrome (chemically induced)</term>
<term>Long QT Syndrome (prevention & control)</term>
<term>Mental Disorders (drug therapy)</term>
<term>Mental Disorders (epidemiology)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Psychotropic Drugs (pharmacology)</term>
<term>Risk Adjustment (methods)</term>
<term>SARS-CoV-2 (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term>
<term>Psychotropic Drugs</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Long QT Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Mental Disorders</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Mental Disorders</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Drug Therapy, Combination</term>
<term>Risk Adjustment</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Long QT Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Comorbidity</term>
<term>Drug Interactions</term>
<term>Humans</term>
<term>Pandemics</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32446195</PMID>
<DateCompleted><Year>2020</Year>
<Month>09</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1876-2026</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>52</Volume>
<PubDate><Year>2020</Year>
<Month>08</Month>
</PubDate>
</JournalIssue>
<Title>Asian journal of psychiatry</Title>
<ISOAbbreviation>Asian J Psychiatr</ISOAbbreviation>
</Journal>
<ArticleTitle>Interactions of recommended COVID-19 drugs with commonly used psychotropics.</ArticleTitle>
<Pagination><MedlinePgn>102173</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1876-2018(20)30285-9</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajp.2020.102173</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chatterjee</LastName>
<ForeName>Seshadri Sekhar</ForeName>
<Initials>SS</Initials>
<AffiliationInfo><Affiliation>Department of Psychiatry, Diamond Harbour Medical College, West Bengal, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Malathesh</LastName>
<ForeName>Barikar C</ForeName>
<Initials>BC</Initials>
<AffiliationInfo><Affiliation>Department of Psychiatry, NIMHANS, Bengaluru, India. Electronic address: bc.malathesh@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Das</LastName>
<ForeName>Soumitra</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>NWMH, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Singh</LastName>
<ForeName>Om Prakash</ForeName>
<Initials>OP</Initials>
<AffiliationInfo><Affiliation>Department of Psychiatry, West Bengal University of Health Sciences, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>05</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Asian J Psychiatr</MedlineTA>
<NlmUniqueID>101517820</NlmUniqueID>
<ISSNLinking>1876-2018</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011619">Psychotropic Drugs</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004347" MajorTopicYN="N">Drug Interactions</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008133" MajorTopicYN="Y">Long QT Syndrome</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011619" MajorTopicYN="N">Psychotropic Drugs</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020379" MajorTopicYN="N">Risk Adjustment</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword>
<Keyword MajorTopicYN="Y">Drug interaction</Keyword>
<Keyword MajorTopicYN="Y">Hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="Y">Psychotropics</Keyword>
<Keyword MajorTopicYN="Y">Ritonavir/Lopinavir</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>05</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>05</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>10</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32446195</ArticleId>
<ArticleId IdType="pii">S1876-2018(20)30285-9</ArticleId>
<ArticleId IdType="doi">10.1016/j.ajp.2020.102173</ArticleId>
<ArticleId IdType="pmc">PMC7239782</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Curr Psychiatry Rep. 2012 Aug;14(4):376-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22707017</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychosomatics. 2018 Mar - Apr;59(2):105-122</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29275963</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Pharmacother. 2006 Jan;40(1):147-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16368918</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Drugs. 2003;63(8):769-802</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12662125</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 May 12;323(18):1824-1836</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32282022</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Asian J Psychiatr. 2020 Jun;51:102071</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32334407</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Asian J Psychiatr. 2020 Apr;50:102100</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32354694</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Drug Saf. 2007;30(1):47-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17194170</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001608 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001608 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:32446195 |texte= Interactions of recommended COVID-19 drugs with commonly used psychotropics. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32446195" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |